Total lab automation is referred as the combination of the analyzers or the work cells with the pre-analytical samples management and transportation system governed by process of the control software. It is a key feature for developing the efficacy and cost containment of the laboratory services. It is important that the implementation of the fully integrated pre-analytical and analytical systems improves the efficacy of the specimen processing, reduces the number of laboratory errors that may occurs during sorting, labelling and aliquoting, preserves sample quality and improves the reliability clinical chemistry testing. It has various advantage like it can significantly upgrade the time interval from the time of the submission of process till the time of the completion of the process, upgrade the length of stay in the emergency department and accelerate the process of the diagnosis which increases the quality of the care. It is used in the increasing the productivity and increasing the experimentation quality of the data. It also poses some of the major disadvantages like higher costs as it may make difficult for the small and medium sized market players to setup the total lab automation, developed expenditure for supplies, requirement of the great space, overcrowding of the staff, increase in the noise and heat production, various problems in the bio specimen management, psychological dependence and others.
COVID-19 Scenario Analysis:
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis
Increase in the gap between the availability of trained professionals and demand for laboratory procedures is expected to increase the growth of the market. Accuracy and the reproducibility of the lab automations are also helping to increase the growth of the market. Safety of the staff, decrease in the volumes of the samples and the cost cutting of the processes are also the factors responsible for the growth of the market. Moreover, increase in number of infected patients can also help increase the diagnostic tests done of the patients, which can create opportunity for the growth of the market. Increase in number of clinical development studies can also help to increase the growth of the total lab automation market.
However, high cost of the setup and maintenance of the total lab automation poses the key restraints in the growth of the market. Furthermore, the lack of the risk-taking capabilities of the labs and evidence-based cost effectiveness can also hamper the growth of the total lab automation market.
New product launches to flourish the market:
In February 2020, BD Kiestra ReadA was approved by the U.S FDA, which was created by Becton, Dickinson and Company. This device improves the operational efficacy in the microbiology laboratories.
In October 2019, the new product was announced under Protean Workcell to automate the discovery of the drug and the genomics applications for biotech companies by Hudson Robotic Inc.
Surge in the usage of the total lab automation:
The increase in the number of diseases and the diagnosis over it can help to increase the usage of the total lab automations. The rise in the efficacy and the reproducibility of the results can also help to surge the usage of the total lab automation.
Key benefits of the report:
- This study presents the analytical depiction of the global total lab automation industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global total lab automation market share.
- The current market is quantitatively analyzed global total lab automation market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global total lab automation market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the total lab automation market research report:
- What are the leading market players active in the total lab automation market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Total Lab Automation Market, by Equipment Report Highlights
| Aspects | Details |
 By Equipment |
|
 By Software |
|
 By Application |
|
 By Region |
|
 Key Market Players | Agilent Technologies, Inc., others., Hudson Robotics, Inc., Sysmex Corporation, PerkinElmer, F. Hoffmann-La Roche AG, Abbott Laboratories, Tecan Group Ltd., Siemens Healthineers AG, Inpeco SpA, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Synchron Lab Automation |
Loading Table Of Content...
